Mead Johnson Nutrition CO (MJN) reported quarterly earnings results on Thursday, Jul-28-2016. The company said it had a profit of $0.88 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.10. Analysts had a consensus of $0.78. The company posted revenue of $941.50 million in the period, compared to analysts expectations of $963.64 million. The company’s revenue was down -8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.76 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Upgraded by JP Morgan to ” Overweight” on Jul 26, 2016. Mead Johnson Nutrition CO was Upgraded by BofA/Merrill to ” Neutral” on Jul 13, 2016.
Mead Johnson Nutrition CO closed down -1.71 points or -1.87% at $89.89 with 40,16,915 shares getting traded on Thursday. Post opening the session at $91.3, the shares hit an intraday low of $87.17 and an intraday high of $91.5 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
In a different news, on May 3, 2016, Christoper Richard Stratton (SVP and President, Asia) sold 33,730 shares at $86.68 per share price. According to the SEC, on Dec 14, 2015, Michel Martinus Gerardus Cup (CFO) purchased 4,000 shares at $76.50 per share price. On Nov 25, 2015, Robert S Singer (director) sold 4,000 shares at $81.77 per share price, according to the Form-4 filing with the securities and exchange commission.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.